Results 151 to 160 of about 34,805 (291)
ABSTRACT Background DESyne BDS Plus represents a novel triple drug therapy (TRx) applied on a coronary stent platform eluting the antiproliferative drug Sirolimus along with two anticoagulants (Rivaroxaban and Argatroban) to reduce the site‐specific thrombotic risk.
Stefan Verheye+19 more
wiley +1 more source
The Effect of Chemical Lumbar Sympathetic Neurolysis in Peripheral Arterial Occlusive Disease: Buerger's Disease vs. Arteriosclerosis Obliterans [PDF]
Tae Hyung Han
openalex +1 more source
ABSTRACT Background Despite achieving complete revascularization, patients with coronary artery disease (CAD) may experience adverse outcomes, potentially attributable to coronary microvascular dysfunction (CMD). Coronary flow reserve (CFR), which integrates both epicardial and microvascular coronary function, and a reduced CFR following complete ...
Jingjing Liu+3 more
wiley +1 more source
ABSTRACT Background Mortality in patients with cardiogenic shock (CS) remains high despite advanced treatment strategies in CS patients, underlining the need for the identification of predictors of prognosis in CS patients. Therefore, the present study investigates the prognostic impact of coronary chronic total occlusions (CTO) in patients with CS ...
Michael Behnes+15 more
wiley +1 more source
Septic Gangrene and Thrombophlebitis Following Leech Therapy in a Patient with Undiagnosed Arterial Occlusive Disease: A Case Report. [PDF]
Ostovar M+4 more
europepmc +1 more source
Impact of race on the treatment for peripheral arterial occlusive disease
Thomas S. Huber+7 more
openalex +1 more source
Lack of functional benefits following infrainguinal bypass in peripheral arterial occlusive disease patients [PDF]
Andrew W. Gardner, Lois A. Killewich
openalex +1 more source
ABSTRACT Background Cardiac computed tomography (CT) is a well‐established process used to diagnose coronary artery disease; however, its specific advantages in predicting the use of atherectomy devices during percutaneous coronary intervention (PCI) for moderate to severe calcified lesions remain to be determined.
Yasuhiro Nakano+19 more
wiley +1 more source
DNA Damage in Pulmonary Arterial Hypertension and Veno-Occlusive Disease-FANCL as Dual Rescue? [PDF]
Pak O, Weissmann N, Sommer N.
europepmc +1 more source
Medical Therapy of Peripheral Arterial Occlusive Disease
John P. Cooke, O. Adrian
openalex +1 more source